Single-cell encoded gene silencing for high-throughput combinatorial siRNA screening.

Area of Science:

• Biotechnology
• Molecular Biology
• Drug Discovery

Background:

• Combinatorial small interfering RNA (siRNA) holds potential for drug discovery but identifying effective combinations is difficult.
• Current methods for large-scale siRNA screening are time-consuming and costly.

Purpose of the Study:

• To develop a high-throughput technology for systematic screening of siRNA-based cocktail therapeutics.
• To identify effective siRNA combinations for anti-cancer applications.

Main Methods:

• Utilized composite micro-carriers responsive to near-infrared light and magnetic fields for photoporation-facilitated siRNA transfection.
• Employed single-cell-based analyses for high-throughput screening of randomized gene silencing.
• Screened over 1300 siRNA combinations targeting tumor growth-related genes.

Main Results:

• Discovered effective 3-siRNA formulations for anti-cancer therapy.
• Highlighted the critical role of inhibiting Cyclin D1 and survivin for synergistic efficacy.
• Identified complementary targets that enhance therapeutic effects.

Conclusions:

• The developed technology significantly reduces time and cost for large-scale siRNA screening.
• This approach provides novel insights into siRNA pharmacology not achievable with existing methods.
• Enables efficient discovery of potent siRNA drug combinations.